Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

472.27 +10.14 (+2.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,326,433
Open 466.51
Bid (Size) 403.90 (1)
Ask (Size) 405.00 (1)
Prev. Close 462.13
Today's Range 462.06 - 473.37
52wk Range 377.85 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Vertex Pharmaceuticals Stock Dives After Q2 Earnings, Phase 2 Results For VX-993
Vertex Pharmaceuticals announces financial results for the second quarter after the market close on Monday. Here's a rundown of the report. 
Via Benzinga

Performance

YTD
+16.4%
+16.4%
1 Month
+2.8%
+2.8%
3 Month
-5.6%
-5.6%
6 Month
+0.4%
+0.4%
1 Year
-1.0%
-1.0%

More News

Read More
Which stocks are moving after the closing bell on Monday?
Via Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Stock Plummets 13% After Discontinuing VX-993 Despite Q2 Earnings Beat
Via Chartmill
Topics Earnings
Earnings Scheduled For August 4, 2025
Via Benzinga
Vertex Crashes After Pain Drug Flop Outweighs Second-Quarter Beat
Via Investor's Business Daily
Topics ETFs
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q2 Sales Beat Estimates But Stock Drops 13.5%
Via StockStory
Topics Earnings
Vertex Reports Second Quarter 2025 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Likely To Report Q2 Profit; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Stock Market Today: US Stocks Likely To Open Higher Despite Weak Jobs Report—Palantir, Vertex Pharma In Focus
Via Benzinga
What To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 Earnings
Via StockStory
Topics Artificial Intelligence Economy World Trade
3 Unstoppable Stocks to Buy in August
Via The Motley Fool
Topics Intellectual Property
Here's How Much $1000 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
Via Benzinga
Examining the Future: Vertex Pharmaceuticals's Earnings Outlook
Via Benzinga
2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now
Via The Motley Fool
The 3 Things That Matter for Vertex Pharmaceuticals Now
Via The Motley Fool
3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
Via The Motley Fool
3 Top Growth Stocks to Buy in the Second Half of 2025
Via The Motley Fool
Topics Artificial Intelligence
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
Via Benzinga
3 Cash-Burning Stocks Walking a Fine Line
Via StockStory
Topics Bankruptcy Economy
Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain
From Vertex Pharmaceuticals Incorporated
Via Business Wire
My 3 Top Stocks to Buy in a Market That's Highly Volatile (Again)
Via The Motley Fool
Topics Artificial Intelligence Energy World Trade
The Best Stocks to Invest $1,000 in Right Now
Via The Motley Fool
Topics Artificial Intelligence

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 472.27
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 08/04/25 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 122.52B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 123B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.